Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
105.90
-5.22 (-4.70%)
Jul 20, 2026, 4:00 PM EDT - Market closed
Monopar Therapeutics Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Buy Maintains $103 | Buy | Maintains | $103 | -2.74% | Jun 30, 2026 |
| BTIG | BTIG | Buy Reiterates $104 → $117 | Buy | Reiterates | $104 → $117 | +10.48% | Jun 30, 2026 |
| JonesTrading | JonesTrading | Buy Maintains $130 | Buy | Maintains | $130 | +22.76% | Jun 29, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $101 | Buy | Maintains | $101 | -4.63% | Jun 29, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $105 | Buy | Reiterates | $105 | -0.85% | Jun 29, 2026 |
| Barclays | Barclays | Buy Maintains $125 | Buy | Maintains | $125 | +18.04% | Jun 29, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $115 | Buy | Maintains | $115 | +8.59% | May 18, 2026 |
Unknown Analyst Leerink Partners No rating | Leerink Partners | Buy Reiterates $115 | Buy | Reiterates | $115 | +8.59% | May 15, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.